Diabetes, Vol 44, Issue 2 161-164, Copyright © 1995 by American Diabetes Association

ARTICLES

Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy?

Q Wang, DG Dills, R Klein, BE Klein and SE Moss
Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison.

We evaluated the relationship of insulin-like growth factor (IGF)-I to incidence and progression of diabetic retinopathy over a 6-year interval in a large population-based study of diabetes in southern Wisconsin. Participants included people with younger-onset diabetes (n = 66 adolescents, n = 661 adults > or = 18 years of age) and older-onset diabetes (n = 285 for those using insulin, n = 248 for those not using insulin). Fundus photographs were graded in a masked fashion using standardized protocols to determine the severity of retinopathy in each eye. Serum IGF-I levels were measured during 1984-1986 using a double-antibody radioimmunoassay. Mean IGF-I was highest in adolescents (499.1 micrograms/l), lower in younger-onset adult (280.1 micrograms/l), and lowest in the older-onset group (205.7 and 221.2 micrograms/l for older-onset group using insulin and not using insulin, respectively). The incidence of retinopathy was not significantly higher in people with higher IGF-I levels in any group. The odds of developing diabetic retinopathy in 6 years for each 10 micrograms/l increase in IGF-I after controlling for age, glycosylated hemoglobin, and duration of diabetes at baseline was 1.21 (95% confidence interval [CI] 0.95-1.54) for adolescents; 1.00 (95% CI 0.93-1.08) for younger-onset adults; 0.93 (95% CI 0.85-1.02) for the older-onset group using insulin; and 0.99 (95% CI 0.95-1.04) for the older-onset group not using insulin. In summary, IGF-I was not associated with 6-year incidence or progression of diabetic retinopathy in any of the groups.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Delafontaine, Y.-H. Song, and Y. Li Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 435 - 444. [Abstract] [Full Text]

				F. F. Lauszus, J. G. Klebe, T. Bek, and A. Flyvbjerg Increased Serum IGF-I During Pregnancy Is Associated With Progression of Diabetic Retinopathy Diabetes, March 1, 2003; 52(3): 852 - 856. [Abstract] [Full Text] [PDF]

				E. A. Koller, L. Green, J. M. Gertner, M. Bost, and S. N. Malozowski Retinal Changes Mimicking Diabetic Retinopathy in Two Nondiabetic, Growth Hormone-Treated Patients J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2380 - 2383. [Abstract] [Full Text]

				E Chantelau Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy Br. J. Ophthalmol., July 1, 1998; 82(7): 725 - 730. [Abstract] [Full Text]

				J. A. M. J. L. Janssen, M. L. Jacobs, F. H. M. Derkx, R. F. A. Weber, A. J. van der Lely, and S. W. J. Lamberts Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 (IGFBP-1), and IGFBP-3 and Their Relationships to the Presence of Diabetic Retinopathy and Glomerular Hyperfiltration in Insulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2809 - 2815. [Abstract] [Full Text] [PDF]